Home / Explore Insights / High-dose immunosuppressive therapy (HDIT) for severe systemic sclerosis (SSc): Long-term survivors show continued improvement of function and skin with stability in the lungs
/ Insights / Explore Insights / High Dose Immunosuppressive Therapy Hdit For Severe Systemic Sclerosis Ssc Long Term Survivors Show Continued Improvement Of Function And Skin With Stability In The Lungs
High-dose immunosuppressive therapy (HDIT) for severe systemic sclerosis (SSc): Long-term survivors show continued improvement of function and skin with stability in the lungs
McSweeney, PA, Furst DE, Crofford, L, et al.
Blood
ADCT
12/31/2003
Publication